Toronto Dominion Bank
PNT

Toronto Dominion Bank’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Toronto Dominion Bank’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-134
Closed -$894 – 1882
2023
Q3 		$894 Hold
134
– – ﹤0.01% 1428
2023
Q2 		$1K Buy
+134
New +$1.18K ﹤0.01% 1476

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Toronto Dominion Bank's PNT Position: Q4 2023 in Review

Toronto Dominion Bank sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 134 shares — an estimated $894 sold.

Toronto Dominion Bank first reported a position in PNT in Q2 2023 and held it in 2 quarters. The position peaked at $1K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Toronto Dominion Bank reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Toronto Dominion Bank sold 134 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $894.
  • Toronto Dominion Bank first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Toronto Dominion Bank's POINT Biopharma Global Inc. Common Stock position peaked at $1K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Toronto Dominion Bank's 13F filing for Q4 2023, filed 13 Feb 2024.